1. Leape, LL, Brennan, TA, Laird, N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
Google Scholar | Crossref | Medline | ISI2. Bates, DW, Boyle, DL, Vander Vliet, MB, Schneider, J, Leape, L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
Google Scholar | Crossref | Medline | ISI3. Morimoto, T, Gandhi, TK, Seger, AC, Hsieh, TC, Bates, DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13:306-314.
Google Scholar | Crossref | Medline4. Laatikainen, O, Miettunen, J, Sneck, S, Lehtiniemi, H, Tenhunen, O, Turpeinen, M. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. Eur J Clin Pharmacol. 2017;73:1539-1549.
Google Scholar | Crossref | Medline5. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) . Contemporary view of medication-related harm. A new paradigm. National Coordinating Council for Medication Error Reporting and Prevention website. 2015. Accessed November 20, 2020. https://www.nccmerp.org/sites/default/files/nccmerp_fact_sheet_2015-02-v91.pdf
Google Scholar6. European Medical Agency, Heads of Medicines Agencies . Guideline on good pharmacovigilance practices (GVP) annex I - definitions (Rev 4). European Medical Agency website. 2017. Accessed November 20, 2020. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf
Google Scholar7. Donaldson, LJ, Kelley, ET, Dhingra-Kumar, N, Kieny, MP, Sheikh, A. Medication without harm: WHO’s third global patient safety challenge. Lancet. 2017;389:1680-1681.
Google Scholar | Crossref | Medline8. Jha, AK, Prasopa-Plaizier, N, Larizgoitia, I, Bates, DW. Patient safety research: an overview of the global evidence. Qual Saf Health Care. 2010;19:42-47.
Google Scholar | Crossref | Medline9. Brennan, TA, Leape, LL, Laird, NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
Google Scholar | Crossref | Medline | ISI10. Bates, DW, Cullen, DJ, Laird, N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE prevention study group. JAMA. 1995;274:29-34.
Google Scholar | Crossref | Medline | ISI11. Morimoto, T, Sakuma, M, Matsui, K, et al. Incidence of adverse drug events and medication errors in Japan: the JADE study. J Gen Intern Med. 2011;26:148-153.
Google Scholar | Crossref | Medline | ISI12. Panagioti, M, Khan, K, Keers, RN, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ. 2019;366:l4185.
Google Scholar | Crossref | Medline13. Bates, DW, Spell, N, Cullen, DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA. 1997;277:307-311.
Google Scholar | Crossref | Medline | ISI14. Classen, DC, Pestotnik, SL, Evans, RS, Lloyd, JF, Burke, JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
Google Scholar | Crossref | Medline | ISI15. Batel Marques, F, Penedones, A, Mendes, D, Alves, C. A systematic review of observational studies evaluating costs of adverse drug reactions. Clinicoecon Outcomes Res. 2016;8:413-426.
Google Scholar | Crossref | Medline16. Formica, D, Sultana, J, Cutroneo, PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17:681-695.
Google Scholar | Crossref | Medline17. Kaushal, R, Bates, DW, Landrigan, C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114-2120.
Google Scholar | Crossref | Medline | ISI18. Gates, PJ, Meyerson, SA, Baysari, MT, Lehmann, CU, Westbrook, JI. Preventable adverse drug events among inpatients: a systematic review. Pediatrics. 2018;142:e20180805.
Google Scholar | Crossref | Medline19. Temple, ME, Robinson, RF, Miller, JC, Hayes, JR, Nahata, MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf. 2004;27:819-829.
Google Scholar | Crossref | Medline | ISI20. Baniasadi, S, Fahimi, F, Shalviri, G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102:408-411.
Google Scholar | Crossref | Medline21. Priyadharsini, R, Surendiran, A, Adithan, C, Sreenivasan, S, Sahoo, FK. A study of adverse drug reactions in pediatric patients. J Pharmacol Pharmacother. 2011;2:277-280.
Google Scholar | Crossref | Medline22. Sakuma, M, Ida, H, Nakamura, T, et al. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study. BMJ Qual Saf. 2014;23:830-837.
Google Scholar | Crossref | Medline23. Glanzmann, C, Frey, B, Meier, CR, Vonbach, P. Analysis of medication prescribing errors in critically ill children. Eur J Pediatr. 2015;174:1347-1355.
Google Scholar | Crossref | Medline24. Easton-Carter, KL, Chapman, CB, Brien, JE. Emergency department attendances associated with drug-related problems in paediatrics. J Paediatr Child Health. 2003;39:124-129.
Google Scholar | Crossref | Medline | ISI25. Easton, KL, Chapman, CB, Brien, JA. Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol. 2004;57:611-615.
Google Scholar | Crossref | Medline | ISI26. Kunac, DL, Kennedy, J, Austin, N, Reith, D. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs. 2009;11:153-160.
Google Scholar | Crossref | Medline27. Saqib, A, Sarwar, MR, Sarfraz, M, Iftikhar, S. Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: a multicenter, cross-sectional study in Lahore, Pakistan. BMC Pharmacol Toxicol. 2018;19:34.
Google Scholar | Crossref | Medline28. Health Statistics Office, Statistics and Information Department, Ministry of Health, Labour and Welfare . Summary of patient survey (2017). Portal Site of Official Statistics of Japan. 2019. Accessed September 20, 2020. https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031790640&fileKind=1 [in Japanese].
Google Scholar29. Social Statistics Office, Statistics and Information Department, Ministry of Health, Labour and Welfare . Statistics of medical care activities in public health insurance (2019). Ministry of Health, Labour and Welfare website. 2020. Accessed September 20, 2020. https://www.mhlw.go.jp/toukei/saikin/hw/sinryo/tyosa19/dl/ika.pdf [in Japanese].
Google Scholar30. Du, W, Tutag Lehr, V, Caverly, M, Kelm, L, Reeves, J, Lieh-Lai, M. Incidence and costs of adverse drug reactions in a tertiary care pediatric intensive care unit. J Clin Pharmacol. 2013;53:567-573.
Google Scholar | Crossref | Medline31. Health Statistics Office, Statistics and Information Department, Ministry of Health, Labour and Welfare . Estimates of national medical care expenditure (2017). Ministry of Health, Labour and Welfare website. 2019. Accessed September 20, 2020. https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/17/dl/toukei.pdf [in Japanese].
Google Scholar32. Leung, AA, Keohane, C, Amato, M, et al. Impact of vendor computerized physician order entry in community hospitals. J Gen Intern Med. 2012;27:801-807.
Google Scholar | Crossref | Medline | ISI33. Malfara, M, Pernassi, M, Aragon, D, Carlotti, A. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit. Int J Clin Pharm. 2018;40:513-519.
Google Scholar | Crossref | Medline34. Akazawa, M, Yongue, J, Ikeda, S, Satoh, T. Considering economic analyses in the revision of the preventive vaccination law: a new direction for health policy-making in Japan? Health Policy. 2014;118:127-134.
Google Scholar | Crossref | Medline35. Infections Disease Sectional Committee, Ministry of Health, Labour and Welfare . Final subcommittee on vaccine evaluation report. Ministry of Health, Labour and Welfare website. 2011. Accessed September 20, 2020. https://www.mhlw.go.jp/stf/shingi/2r98520000014wdd-att/2r98520000014weu.pdf [in Japanese].
Google Scholar